Overview

HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia

Status:
Not yet recruiting
Trial end date:
2023-05-10
Target enrollment:
Participant gender:
Summary
To evaluate the safety, tolerability , pharmacokinetics and Preliminary Efficacy of HEC53856 Capsules in Patients With Non-dialysis Renal Anemia.
Phase:
Phase 1
Details
Lead Sponsor:
Sunshine Lake Pharma Co., Ltd.
Collaborator:
Nicoya Therapeutics (Shanghai) Co., Ltd.